<DOC>
	<DOCNO>NCT01645358</DOCNO>
	<brief_summary>Lack tolerance treatment , make interface choice non-invasive ventilation ( NIV ) one key factor . To date helmet rarely use Acute Hypercapnic Respiratory Failure ( AHRF ) , large dead space , despite hypoxic respiratory failure , largely employ `` rotate '' strategy facial mask poorly tolerate . In multicenter randomize control trial , investigator compare clinical efficacy new helmet design specifically improve performance chronic obstructive pulmonary disease ( COPD ) versus full face mask episode AHRF .</brief_summary>
	<brief_title>Helmet Ventilation Acute Hypercapnic Respiratory Failure</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Hypercapnia</mesh_term>
	<criteria>pH &lt; 7,35 PaCO2 &gt; 45 mmHg respiratory rate &gt; 20 b/min hypoxic respiratory failure coma inability stand NIV lack inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>COPD</keyword>
	<keyword>NIV</keyword>
	<keyword>Acute Hypercapnic Respiratory Failure</keyword>
	<keyword>COPD patient hypercapnic respiratory failure</keyword>
</DOC>